Standout Papers

Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis 2022 2026 2023 2024173
  1. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis (2022)
    Zhuoran Wang, Lingyan Wang et al. Biomedicine & Pharmacotherapy

Immediate Impact

50 standout
Sub-graph 1 of 23

Citing Papers

Pharmacological Potential of Kaempferol, a Flavonoid in the Management of Pathogenesis via Modulation of Inflammation and Other Biological Activities
2024 Standout
GPX4, ferroptosis, and diseases
2024 Standout
1 intermediate paper

Works of Lingyan Wang being referenced

Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis
2022 Standout
Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling.
2015

Author Peers

Author Last Decade Papers Cites
Lingyan Wang 297 47 114 102 26 579
Rongrong Li 275 50 70 80 34 702
Yanni Lv 373 71 107 40 37 689
Yao Zhou 288 45 47 181 32 661
Tingting Bao 193 42 71 60 35 536
Yun Wu 227 45 47 64 22 530
Huang Ding 323 56 96 40 37 608
Jinghua Zhang 413 49 48 45 38 730
Juan Yang 334 12 90 68 19 653
Li Yan 310 117 182 33 30 632
Aiying Li 303 26 73 65 51 675

All Works

Loading papers...

Rankless by CCL
2026